Arena Capital Advisors’s Barinthus Biotherapeutics BRNS Stock Holding History

Arena Capital Advisors’s Portfolio BRNS Stock Details BRNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-30,698	Closed	-$341K	–	303
2021 Q4	$341K	Hold	30,698	–	–	0.03%	207
2021 Q3	$483K	Hold	30,698	–	–	0.04%	217
2021 Q2	$515K	Buy	+30,698	New	+$454K	0.04%	278

Other funds holding BRNS

Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return

DC Funds Mclean, Virginia $1.49M AUM 18.57% 1-Year Est. Return

Liontrust Investment Partners London, United Kingdom $5.86B AUM 23.75% 1-Year Est. Return

BlueCrest Capital Management St Helier, Jersey $1.06B AUM 20.01% 1-Year Est. Return

Johns Hopkins University Baltimore, Maryland $1.38B AUM 9.48% 1-Year Est. Return

Millennium Management

Millennium Management New York $134B AUM 35.51% 1-Year Est. Return

Ipswich Investment Management Beverly, Massachusetts $426M AUM 24.58% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return

M&G Investment Management London, United Kingdom $28.2B AUM 25.87% 1-Year Est. Return